Delivery Order SPE2DB24D2101-SPE2DB25FKPGX
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $44,091.96 to AmerisourceBergen Drug Corp for the supply of Samsca 30 mg tablets (10-count units) on July 21, 2025, with an ultimate completion date of August 11, 2025. This is a firm fixed price, non-set-aside delivery order issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 global pharmaceutical support vehicle running through December 2026....
- The Defense Logistics Agency awarded a delivery order valued at $21,247.20 to AmerisourceBergen Drug Corp for Samsca 15 mg tablets (10-count units) on August 11, 2025, with an ultimate completion date of September 2, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical supply...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,965.88 firm-fixed-price delivery order is for the medication Samsca (tolvaptan) 30 mg tablets, with an ultimate completion date of April 15, 2022. The award is a delivery order against Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of Samsca 15 mg tablets, a medication used to treat certain hyponatremia conditions. The delivery order has a ceiling value of $10,269.78 and a completion date of November 5, 2024. The contract is a firm-fixed-price arrangement. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on July 28, 2025, for the supply of Samsca 15 mg tablets (10-count packages) valued at $7,082.40 with a firm fixed price structure. The contract, which is not set-aside and was competitively awarded, requires completion by August 18, 2025, with performance to be executed from the company's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen Drug...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,623.60 contract is for the delivery of the prescription medication Samsca 15 mg tablets, with a performance period ending on May 14, 2025. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of SAMSCA 15 mg tablets (10 count) with a ceiling value of $10,623.60. This firm fixed-price delivery order, which is not set-aside, is scheduled for completion by September 9, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a continuation of the company's role as a critical pharmaceutical supplier to...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of SAMSCA 15 MG TABLET 10S. The award, valued at $62,383.44, has an ultimate completion date of September 16, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for providing a...
- The Defense Logistics Agency awarded a $10,623.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp for SAMSCA 15 mg tablets (10-count units) with an ultimate completion date of September 15, 2025. This non-set-aside competitive award was issued on August 22, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was selected through...
- The Defense Logistics Agency awarded a $10,647 delivery order to Amerisourcebergen Drug Corporation for 30 mg SAMSCA tablets. The firm fixed price order calls for delivery of 10 boxes of the pharmaceutical product to a facility in Conshohocken, Pennsylvania by mid-August 2023. The prime contractor, Amerisourcebergen, will fulfill the order from its corporate headquarters. The Defense Logistics Agency routinely issues such requirements on an indefinite-delivery/indefinite-quantity contract to...
- SPE2DB24D2101Indefinite Delivery Contract
- SPE2DB24D2101-SPE2DB25FKPGXDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,541.20 to AmerisourceBergen Drug Corp for 10 tablets of Samsca 15 mg on September 8, 2025, with an ultimate completion date of September 29, 2025. This firm fixed-price delivery order represents a non-competitive set-aside and is being performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Samsca (tolvaptan) is a vasopressin receptor antagonist used in the treatment of hyponatremia and polycystic kidney disease, indicating this procurement supports federal medical supply needs, likely for military healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026. As a prime pharmaceutical vendor to the Defense Logistics Agency, AmerisourceBergen supplies a comprehensive range of medications and medical commodities to support military healthcare programs globally. The company's established relationship with DLA and demonstrated capability to fulfill federal medical procurement requirements positions it as a critical supplier within the Defense Health Agency's pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.5k | 9/8/25 |